cnbc_topnews

Pirro appears to drop plans to appeal criminal investigation of Fed Chair Powell

jeanine pirro appeared to drop plans to appeal a ruling against her criminal investigation of fed chair jerome powell. she instead said she'll file a motion to vacate judge james boasberg's order quashing her subpoenas to the fed.

the shift came on cnn's "state of the union" sunday. pirro's appeal was due monday. boasberg had ruled her office presented no specific evidence of wrongdoing, while "a mountain of evidence" suggested the investigation aimed to pressure powell over interest rates.

pirro said she wants a report from fed inspector general michael horowitz. she declined to commit to ending the investigation if horowitz finds no wrongdoing. powell said wednesday he'd stay on the board after his chair term expires until the legal threat is resolved.

source: cnbc_topnews
sentiment: +0.20 · impact: 0.80

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

oil started the week higher on a disputed claim of an iranian strike on a u.s. navy ship in the strait of hormuz. the report, which hasn't been confirmed by u.s. officials, added fresh volatility to crude markets. the strait of hormuz is a key chokepoint

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

source: marketwatch_top sentiment: -0.70 · impact: 0.80

Warsh's take on Fed independence is met with confusion and some concern

kevin warsh, trump's pick to lead the fed, is drawing confusion from six former fed officials over his views on fed independence. the sticking point: he draws a line between monetary policy — which he says should be "strictly independent" — and "non-monetary matters" like international

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

the weight-loss and diabetes drug boom is creating a bubble risk for pharma, according to a deloitte report out monday. r&d returns for the top 20 pharma companies hit 7% for a third straight year, driven almost entirely by glp-1 drugs like wegovy and zepbound. strip those out

Read more

Oil prices climb after disputed report of Iran strike on U.S. warship in the Strait of Hormuz

The markets are in the early stages of pricing in stagflation. Here’s what happens next.

Warsh's take on Fed independence is met with confusion and some concern

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds